Advertisement
Canada markets close in 5 hours 33 minutes

  • S&P/TSX

    21,727.27
    -146.45 (-0.67%)
     

  • S&P 500

    5,010.19
    -61.44 (-1.21%)
     

  • DOW

    37,807.28
    -653.64 (-1.70%)
     

  • CAD/USD

    0.7296
    -0.0002 (-0.02%)
     

  • CRUDE OIL

    82.31
    -0.50 (-0.60%)
     

  • Bitcoin CAD

    87,378.71
    -2,810.15 (-3.12%)
     

  • CMC Crypto 200

    1,377.13
    -5.45 (-0.39%)
     

  • GOLD FUTURES

    2,336.10
    -2.30 (-0.10%)
     

  • RUSSELL 2000

    1,965.04
    -30.38 (-1.52%)
     

  • 10-Yr Bond

    4.7190
    +0.0670 (+1.44%)
     

  • NASDAQ

    15,494.16
    -218.58 (-1.39%)
     

  • VOLATILITY

    17.23
    +1.26 (+7.88%)
     

  • FTSE

    8,054.08
    +13.70 (+0.17%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6804
    -0.0015 (-0.22%)
     
BREAKING:

HONDA TO SET UP $15B EV PRODUCTION BASE IN CANADA

Automaker to get up to $5B in government assistance for EV battery, assembly plants

Stocks in play: Khiron Life Sciences Corp.

Baystreet.ca

Announced today that, after a successful first year in the Colombian market, the Company adds another significant milestone: its first import of Kuida cosmetic products into the United States. With this first shipment complete, Kuida has become the first Colombian brand to introduce legal CBD products in the U.S. market. Khiron Life Sciences Corp. shares V.KHRN are trading down $0.01 at $1.14.

READ: Ancient Medicines Bring Modern Value to Yield Growth Corp.